Renata J. Ferrari

Partner

ferrari-renata
  • JD, Harvard Law School, 1998; cum laude
  • AB, Harvard College, 1994; cum laude

Qualifications

  • Massachusetts, 1999
  • New York, 1999
  • Board of Advisors, Isabella Stewart Gardner Museum
  • Renata has served as a Lecturer in Law at Boston College Law School.
  • Legal 500 – Green Guide (2023) 
  • LMG Life Sciences Americas Awards “Impact Deal of the Year” for advising Pfizer in $11.6 billion acquisition of Biohaven Pharmaceuticals (2022)
  • China Law & Practice Awards: “Equity Securities Deal of the Year for LianBio IPO” (2022)
  • The Best Lawyers in America Employee Benefits (ERISA) Law “Lawyer of the Year” (2023)
  • The Best Lawyers in America (2016-2023)
  • Chambers USA: America's Leading Lawyers for Business (2013-2022)
  • Boston Magazine “Top Lawyers” (2021)
  • Legal 500 (2013-2020)

Renata J. Ferrari

Partner

Renata Ferrari is co-managing partner of the Boston office and leads the employment, executive compensation and employee benefits group. She advises clients on executive compensation, equity-based and other incentives, deferred compensation, severance plans and other compensatory and benefits arrangements. Renata also advises on the application of securities and tax laws to executives and employers and corporate governance matters. Her practice also includes a focus on compensation and benefits-related issues arising in the context of mergers and acquisitions and other corporate transactions.

Publications

  • Co-author, with Craig E. Marcus, of “Special Considerations in Adopting and Amending Employee Stock Plans,” a chapter in A Practical Guide to SEC Proxy and Compensation Rules, Sixth Edition (2018)
  • Quoted, “#MeToo Provisions In Executive Compensation: Is It Time to Redefine ‘Cause’ and Expand Clawbacks?,” Bloomberg News (July 5, 2018)  
  • Quoted, “Challenges for the Compensation Committee,” Financier Worldwide (October 2014) 

Presentations

  • Speaker, “Top Tips on Executive Compensation Disclosure in Pandemic Year 3,” Women’s 100 Conference (February 2022) 
  • Panelist, "Tying ESG to Executive Pay: Dos and Donts" and "Hot Topics: 30 Practical Nuggets in 30 Minutes,” Annual Proxy Disclosure Conference (October 2021)
  • Panelist, “Hot Topics in Mergers & Acquisitions,” ABA Fall Tax Conference (September 2021) 
  • Panelist, “Hot Topics in Mergers & Acquisitions,” Executive Compensation Virtual 2020 National Institute (November 2020) 
  • Panelist, “Pay for Performance: What Matters Now” and “162(m): Where Things Stand,” Annual Proxy Disclosure Conference (September 2020)
  • Panelist, “Hot Topics in Mergers & Acquisitions,” National Institute on Executive Compensation (November 2019) 
  • Panelist, “Section 162(m) Deductibility (Is There Really Any Grandfathering)” and “Director Pay Disclosures,” Proxys Disclosure Conference (September 2019) 
  • Speaker, “MeToo, Clawbacks, and Executive Compensation in 2019 – Has Anything Changed?” ALI CLE: Executive Compensation 2019--Strategy, Design and Implementation (June 2019)
  • Panelist, “Impact of #MeToo on Executive Compensation—Clawbacks and More,” ABA Fall Tax Meeting (October 2018)
  • Panelist, “Section 162(m) & Tax Reform Changes” and “Hot Topics: 50 Practical Nuggets in 60 Minutes,” Pay Ratio & Proxy Disclosure Conference and Say-on-Pay Workshop (September 2018)
  • Speaker, “#MeToo, Employment Agreements, and the Clawback of Executive Compensation,” ALI CLE: Executive Compensation 2018--Strategy, Design and Implementation (June 2018)
  • JD, Harvard Law School, 1998; cum laude
  • AB, Harvard College, 1994; cum laude

Qualifications

  • Massachusetts, 1999
  • New York, 1999
  • Legal 500 – Green Guide (2023) 
  • LMG Life Sciences Americas Awards “Impact Deal of the Year” for advising Pfizer in $11.6 billion acquisition of Biohaven Pharmaceuticals (2022)
  • China Law & Practice Awards: “Equity Securities Deal of the Year for LianBio IPO” (2022)
  • The Best Lawyers in America Employee Benefits (ERISA) Law “Lawyer of the Year” (2023)
  • The Best Lawyers in America (2016-2023)
  • Chambers USA: America's Leading Lawyers for Business (2013-2022)
  • Boston Magazine “Top Lawyers” (2021)
  • Legal 500 (2013-2020)
Cookie Settings